Skip to content

Quantifying Iron Absorption, Loss and Balance in Endurance Trained Athletes Across a 12-Month Training Cycle

Quantifying Iron Absorption, Loss and Balance in Endurance Trained Athletes Across a 12-Month Training Cycle

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12621001580864
Enrollment
57
Registered
2021-11-18
Start date
2022-01-22
Completion date
2022-04-04
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Iron deficiency (ID) is the most common worldwide nutrient deficiency, is of particular concern to athletes due to the fundamental role of iron in optimal sports performance. Exercise-induced physiologic changes may be a possible explanation for the high rates of ID in athletic cohorts. These mechanisms include iron losses via sweat, gastrointestinal bleeding, hematuria, and repeated inflammatory mediated increases in the iron regulatory hormone hepcidin. Furthermore, in female athletes, the iron losses associated with menstruation add an extra burden that may contribute to the high rates of ID seen in female compared to male athletes (~35% vs ~10%, respectively). Although these mechanisms have been examined in isolation, whether the sustained and combined effects seen in high performance athletes have a meaningful impact on iron metabolism and long-term iron balance is unknown. Therefore, the primary aim of this study is to compare iron absorption, loss and overall balance using iron isotope tracers in endurance trained athletes with recreationally active individuals at regular intervals across a 12-month training cycle. 12 months after the iron isotope tracer is administered, participants will attend the laboratory at 3 monthly intervals for a 12 month period (5 visits). Participants will have a venous blood sample collected and measured for markers of iron status and isotopic the isotopic iron composition, as well as an assessment of hemoglobin mass. Information around habitual dietary intake (specifically iron), menstrual cycle history and training volume will also be collected at each visit. Outcomes of this study will increase our understanding of iron requirements for athletes against those of the general population.

Interventions

The aim of this study is to quantify iron loss, absorption and turnover in 3 different participant cohorts in order to determine more specific recommended daily intake targets for dietary iron. Outcomes of this study will aid in the prevention of iron deficiency and anemia. Three cohorts will be recruited for this study: 1. Male endurance athletes (>50 km of running/race walking per week) 2. Female endurance athletes (>50 km of running/race walking per week) 3. Male, recreationally active indivi

The aim of this study is to quantify iron loss, absorption and turnover in 3 different participant cohorts in order to determine more specific recommended daily intake targets for dietary iron. Outcomes of this study will aid in the prevention of iron deficiency and anemia. Three cohorts will be recruited for this study: 1. Male endurance athletes (>50 km of running/race walking per week) 2. Female endurance athletes (>50 km of running/race walking per week) 3. Male, recreationally active individuals (<2 endurance sessions/week, otherwise healthy). Stable iron isotopes (<10 mg Fe57) will be orally administered to participants with 200 mL of distilled water. 12 months after administration, participants will return for 5 more laboratory visits at 3 month intervals. At each visit (anticipated to last <60 min), a hemoglobin mass assessment and venous blood sample will be collected to determine blood volume, iron status and the isotopic signature. Furthermore, information around habitual dietary intake (specifically iron), menstrual cycle history and training volume will also be collected at each visit. Each visit will be conducted in the morning (between 6-10 am), prior to undertaking any exercise for the day and will be supervised by an accredited sports scientist (ESSA ASpS1). The total study duration for each participant will be 2 years.

Sponsors

Australian Catholic Univeristy
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

Three different cohorts will be recruited: 1. Highly trained male runners and race walkers with a minimum training volume of ~50 km/week. 2. Highly trained female runners and race walkers with a minimum training volume of ~50 km/week. Participants will have regular menstrual cycles (>9 per year; naturally menstruating or on hormonal contraception) 3. Male, recreationally active individuals, not performing more than 2 endurance based exercise sessions per week.

Exclusion criteria

Free from lifestyle and/or metabolic diseases (i.e. obesity, diabetes) BMI >30 kg/m2 Do not meet the required exercise volume Experience large blood loss (surgery/blood donation/pregnancy).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026